Summary

Anal Fistula Treatment Market – Scope of Report
TMR’s report on the global anal fistula treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global anal fistula treatment market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global anal fistula treatment market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the anal fistula treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global anal fistula treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global anal fistula treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global anal fistula treatment market.

The report delves into the competitive landscape of the global anal fistula treatment market. Key players operating in the global anal fistula treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global anal fistula treatment market profiled in this report.

Key Questions Answered in Global anal fistula treatment Market Report
• What is the sales/revenue generated by anal fistula treatment across all regions during the forecast period?
• What are the opportunities in the global anal fistula treatment market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Anal Fistula Treatment Market – Research Objectives and Research Approach
The comprehensive report on the global anal fistula treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global anal fistula treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global anal fistula treatment market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Anal Fistula Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Anal Fistula Treatment Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Anal Fistula Treatment Market Analysis and Forecast, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Treatment Type, 2017–2031
6.3.1. Non-surgical
6.3.1.1. Drugs
6.3.1.2. Others (fibrin glue, adipose stem cell therapy, etc.)
6.3.2. Surgical
6.3.2.1. Fistulotomy
6.3.2.2. Bioprosthetic Plus
6.3.2.3. Advancement Flap Procedures
6.3.2.4. Seton Techniques
6.3.2.5. Others
6.4. Market Attractiveness Analysis, by Treatment Type
7. Global Anal Fistula Treatment Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Intersphincteric
7.3.2. Transsphincteric
7.3.3. Suprasphincteric
7.3.4. Extrasphincteric
7.3.5. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Anal Fistula Treatment Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals & Ambulatory Surgical Centers
8.3.2. Clinics
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Anal Fistula Treatment Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Anal Fistula Treatment Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Treatment Type, 2017–2031
10.3.1. Non-surgical
10.3.1.1. Drugs
10.3.1.2. Others (fibrin glue, adipose stem cell therapy, etc.)
10.3.2. Surgical
10.3.2.1. Fistulotomy
10.3.2.2. Bioprosthetic Plus
10.3.2.3. Advancement Flap Procedures
10.3.2.4. Seton Techniques
10.3.2.5. Others
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Intersphincteric
10.4.2. Transsphincteric
10.4.3. Suprasphincteric
10.4.4. Extrasphincteric
10.4.5. Others
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Hospitals & Ambulatory Surgical Centers
10.5.2. Clinics
10.5.3. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Treatment Type
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe Anal Fistula Treatment Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Treatment Type, 2017–2031
11.3.1. Non-surgical
11.3.1.1. Drugs
11.3.1.2. Others (fibrin glue, adipose stem cell therapy, etc.)
11.3.2. Surgical
11.3.2.1. Fistulotomy
11.3.2.2. Bioprosthetic Plus
11.3.2.3. Advancement Flap Procedures
11.3.2.4. Seton Techniques
11.3.2.5. Others
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Intersphincteric
11.4.2. Transsphincteric
11.4.3. Suprasphincteric
11.4.4. Extrasphincteric
11.4.5. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals & Ambulatory Surgical Centers
11.5.2. Clinics
11.5.3. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Treatment Type
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Anal Fistula Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Treatment Type, 2017–2031
12.3.1. Non-surgical
12.3.1.1. Drugs
12.3.1.2. Others (fibrin glue, adipose stem cell therapy, etc.)
12.3.2. Surgical
12.3.2.1. Fistulotomy
12.3.2.2. Bioprosthetic Plus
12.3.2.3. Advancement Flap Procedures
12.3.2.4. Seton Techniques
12.3.2.5. Others
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Intersphincteric
12.4.2. Transsphincteric
12.4.3. Suprasphincteric
12.4.4. Extrasphincteric
12.4.5. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals & Ambulatory Surgical Centers
12.5.2. Clinics
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Treatment Type
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Anal Fistula Treatment Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Treatment Type, 2017–2031
13.3.1. Non-surgical
13.3.1.1. Drugs
13.3.1.2. Others (fibrin glue, adipose stem cell therapy, etc.)
13.3.2. Surgical
13.3.2.1. Fistulotomy
13.3.2.2. Bioprosthetic Plus
13.3.2.3. Advancement Flap Procedures
13.3.2.4. Seton Techniques
13.3.2.5. Others
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Intersphincteric
13.4.2. Transsphincteric
13.4.3. Suprasphincteric
13.4.4. Extrasphincteric
13.4.5. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals & Ambulatory Surgical Centers
13.5.2. Clinics
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Treatment Type
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Anal Fistula Treatment Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Treatment Type, 2017–2031
14.3.1. Non-surgical
14.3.1.1. Drugs
14.3.1.2. Others (fibrin glue, adipose stem cell therapy, etc.)
14.3.2. Surgical
14.3.2.1. Fistulotomy
14.3.2.2. Bioprosthetic Plus
14.3.2.3. Advancement Flap Procedures
14.3.2.4. Seton Techniques
14.3.2.5. Others
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Intersphincteric
14.4.2. Transsphincteric
14.4.3. Suprasphincteric
14.4.4. Extrasphincteric
14.4.5. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals & Ambulatory Surgical Centers
14.5.2. Clinics
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Treatment Type
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Becton, Dickinson and Company
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Biolitec AG
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Cook Medical
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Gem srl
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. KARL STORZ SE & Co. KG
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Medtronic plc
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. TiGenix NV
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. W.L. Gore & Associates, Inc. (Gore Medical)
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview